Searched for
ENOXAPARIN
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...- In times of war and volatility – A better ratio for long-term investing: 5 stocks with the right PEG ratioThere is only one certainty in terms of the escalating war in the Gulf region: Global markets are going to remain roiled for the foreseeabl...
- Buy Gland Pharma, target price Rs 1,970: Motilal Oswal SecuritiesMotilal Oswal Securities recommends buying Gland Pharma stock. They predict a target price of Rs 1970. The brokerage expects Gland Pharma's...
- Venus Remedies gets marketing approval for anticoagulant drug in Saudi ArabiaVenus Remedies on Monday said it has received approval to market a drug, which prevents blood clots, in Saudi Arabia. The company has recei...
- Gland Pharma shares hit 20% lower circuit after disappointing Q4 resultsGland Pharma's stock prices hit a 20% lower circuit on BSE after the firm reported a 72% YoY drop in net profit to Rs 79 crore in Q4FY23 du...
- Venus Remedies gets good manufacturing certification from Saudi drug regulatorThe Saudi Food and Drug Authority (SFDA) granted the certification which includes first-time approval for pre-filled enoxaparin syringes an...
- Biological E plans to hive off non-vaccine business and sell stakeAccording to rating firm ICRA, BE reported revenues of Rs 2,556.8 crore in FY22, largely driven by the government's Rs 1,500-crore contract...
- Govt frees OLED, liquid crystals imports, Remdesivir exportsIn a separate notification, the Directorate General of Foreign Trade also said that Remdesivir Injection and API, Amphotericin-B Injections...
- Government puts curbs on export of Enoxaparin"The export of Enoxaparin (formulation and API) and intra-venous immunoglobulin (formulation and API) ....has been put under restricted cat...
- Cadila Healthcare Q2 results: Net profit zooms over 6-fold to Rs 3,002 cr on one-time gainConsolidated total revenue from operations of the company stood at Rs 3,784.8 crore for the quarter under consideration. It was Rs 3,658.9 ...
- Third wave fear: Delhi regulator asks pharma firms to keep buffer drug stocks readyThe Drugs Control Department of Delhi has written to the drug manufacturers’ association and the chemists association of the city urging th...
- Cadila inks pact with Italian firm to launch generic product in USThe partners plan to launch the product which is a generic version of Sanofi Aventis's Lovenox (Enoxaparin Sodium Injection) in seven dosag...
- Gland Pharma Q1 results: Net profit rises 12% to Rs 351 crConsolidated revenue from operations of the company stood at Rs 1,153.9 crore for the quarter under consideration. It was Rs 884.2 crore fo...
- DDMA asks pharmacies to display available stock, cost of COVID-19 drugs prominentlyThe drugs are Ivermectin tablets, Doxycyclin tablets/capsule, Methyl Prednisolone tablets and injections, Dexamethasone tablets and injecti...
- Stock of Indian Sputnik V maker gets a shot in the arm; analysts see long runwayThe company reported 34 per cent growth in consolidated net profit at Rs 260.4 crore for March quarter on robust sales.
- India considers allowing import of raw material for manufacturing crude heparinHeparin and its related derivative, the low molecular weight heparin, also known as enoxaparin, is an anticoagulant that has demonstrated i...
- Pricing regulator asks pharma companies to provide stock details to ensure availability of drugsIt has sought details such as production and sale of these drugs in the past two years, stock lying with the company as on date, production...
- Fosun Group injects new life into Gland Pharma dealLast year, the government relaxed the foreign investment rules, allowing global companies to acquire up to 74 per cent in local drug makers...
- Indian-origin hedge fund manager charged with insider trading commits suicideSanjay Valvani, had faced securities fraud and wire fraud charges after he had used confidential information obtained from a former officia...
- Indian-origin hedge fund manager charged with insider tradingSanjay Valvani, 44, reaped unlawful profits of nearly $32 million for hedge funds investing in health care securities by insider trading.
Load More
